CalciMedica, Inc.
CALC · Nasdaq · SIC 2834: Pharmaceutical Preparations
Business Summary
2 Item 1A. Risk Factors 43 Item 1B. Unresolved Staff Comments 88 Item 1C. Cybersecurity 89 Item 2. Properties 90 Item 3. Legal Proceedings 91 Item 4. Mine Safety Disclosures 91 PART II Item 5. Market for Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 92 Item 6. [Reserved ] 92 Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations 93 Item 7A. Quantitative and Qualitative Disclosures About Market Risk 103 Item ...
Next Earnings
Q2 FY2026 — expected 2026-08-11
Key Facts from Earnings Calls
| Type | Subject | Detail | Quarter |
|---|
| topic_mention | CALC | discussed_in_filing Cybersecurity | |
| topic_mention | CALC | discussed_in_filing Cybersecurity | |
| topic_mention | CALC | discussed_in_filing Cybersecurity | |
| topic_mention | CALC | discussed_in_filing Cybersecurity | |
Annual Reports (10-K)
| Filed | Period | Accession | Source | Full Text |
|---|
| 2026-03-03 | 2025-12-31 | 0001193125-26-088147 | EDGAR | 102K words |
| 2025-03-27 | 2024-12-31 | 0000950170-25-046035 | EDGAR | — |
| 2024-03-28 | 2023-12-31 | 0000950170-24-038064 | EDGAR | — |
| 2023-03-09 | 2022-12-31 | 0000950170-23-006795 | EDGAR | — |
| 2022-03-11 | 2021-12-31 | 0001564590-22-009728 | EDGAR | — |
| 2021-03-05 | 2020-12-31 | 0001564590-21-011305 | EDGAR | — |
Quarterly Reports (10-Q)
| Filed | Period | Accession | Source | Full Text |
|---|
| 2025-11-12 | 2025-09-30 | 0001193125-25-277617 | EDGAR | 72K words |
| 2025-08-12 | 2025-06-30 | 0000950170-25-107334 | EDGAR | — |
| 2025-05-14 | 2025-03-31 | 0000950170-25-071421 | EDGAR | — |
| 2024-11-13 | 2024-09-30 | 0000950170-24-126296 | EDGAR | — |
| 2024-08-12 | 2024-06-30 | 0000950170-24-095490 | EDGAR | — |
| 2024-05-13 | 2024-03-31 | 0000950170-24-058744 | EDGAR | — |
| 2023-11-09 | 2023-09-30 | 0000950170-23-062176 | EDGAR | — |
| 2023-08-11 | 2023-06-30 | 0000950170-23-041844 | EDGAR | — |
| 2023-05-12 | 2023-03-31 | 0000950170-23-021775 | EDGAR | — |
| 2022-11-10 | 2022-09-30 | 0001564590-22-037397 | EDGAR | — |
| 2022-08-12 | 2022-06-30 | 0001564590-22-029174 | EDGAR | — |
| 2022-05-12 | 2022-03-31 | 0001564590-22-019611 | EDGAR | — |
Recent Current Reports (8-K)
| Filed | Accession | Source | Full Text |
|---|
| 2026-03-18 | 0001193125-26-114096 | EDGAR | 1K words |
| 2026-03-03 | 0001193125-26-086658 | EDGAR | — |
| 2026-01-28 | 0001193125-26-027462 | EDGAR | — |
| 2026-01-28 | 0001193125-26-025649 | EDGAR | — |
| 2025-11-12 | 0001193125-25-275888 | EDGAR | — |
| 2025-11-06 | 0001193125-25-269526 | EDGAR | — |
| 2025-08-12 | 0000950170-25-106918 | EDGAR | — |
| 2025-06-27 | 0001193125-25-151234 | EDGAR | — |
| 2025-06-06 | 0001193125-25-136297 | EDGAR | — |
| 2025-05-14 | 0000950170-25-070910 | EDGAR | — |
104 total filings indexed. 76 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
Sector Peers
Company Identity
| CIK | 0001534133 |
| Ticker | CALC |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
Get More Data
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile
Stock Quote
AI Readiness Report
Origin Provenance
page leaf: b434a0ad81ed6822a2044383f65b0aaf8288a8d6bd84f167d665e24755d728a5
parent: a5ee26ac1a0ed7f835a43721530ca702e3726233e8051c5ec34cd06a8eac81ef
content hash: 21dcdfa77093faeb350d2b7fde29f4873b9eaa764621699dd72517259de3376e
signed: 2026-04-13T04:44:11.197Z
sources: 18 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf